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Background: Although honeybee venom (BV) has been reported to induce apoptosis in different types of
cancerous cells, its synergistic effects with customary anti-cancer drugs remain largely unknown. In the present
study, we evaluated the cytotoxic effect of BV alone (as a natural product) and the synergistic cytological effects of
this component in combination with [Pd (bpy) (Pi-Pydtc)]NO3 – a novel palladium complex on human T-cell
lymphoblastic leukemia cells. To investigate the cytotoxic effect of the BV alone and in combination with palladium
complex on MOLT-4 cells MTT assay was performed. In order to determine the apoptotic effects of BV separately
and in combination with Pd (II) complex on these cells and its ability to induce apoptosis, morphological
examination, flowcytometric analysis and caspase-3 colorimetric assay were done.
Results: We found that BV induced morphological changes, namely nuclear shrinkage, and inhibited MOLT-4 cell
proliferation; both effects were dose- and time-dependent. Flow cytometry by Annexin-V antibody demonstrated
that BV induced apoptosis in MOLT-4 cells. Furthermore, BV induced apoptosis independently of caspase-3 in these
cells. In addition, we proved a clear synergistic effect of BV on [Pd (bpy) (Pi-Pydtc)]NO3. The apoptotic pathway
activated by BV in combination with Pd complex was caspase-3-dependent.
Conclusions: These observations provide an explanation for the anti-proliferative properties of BV, and suggest that
this agent may be useful for treating lymphoblastic leukemia alone or in combination with chemotherapy drugs
pending further investigations on animal models as preclinical tests.
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Bee venom is a natural substance that contains only
0.1 μg of dry venom [1]. The dry venom has a very com-
plex mixture of such active peptides as melittin, apamin
and adolapine, enzymes including hyaluronidase and
phospholipase A2, biologically active amines such as his-
tamine and epinephrine as well as non-peptide compo-
nents with numerous medicinal properties [2]. Melittin,
a hemolytic and strong cardiotoxic peptide, is the major
active ingredient of BV. This main constituent of bee
venom has been reported to induce apoptosis, and to
produce anti-tumor effects [3,4]. Melittin, which makes
up 50-60% of the dry venom, is a low-molecular-weight* Correspondence: nabiuni@khu.ac.ir
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distribution, and reproduction in any mediumprotein (2846.46 Da), which is composed of 26 amino
acids. It is found as a tetramer in the poison sac of the
bee, but when influencing a cell, it acts as a monomer [5].
BV has been used as a traditional medicine to treat
various diseases such as arthritis, rheumatism, back pain
and skin diseases [2]. Besides, recent studies have
reported that BV causes growth arrest and exerts cyto-
toxic effects on various types of cancerous cells [6-11].
The cytotoxic effects mediated through the activation of
PLA2 by melittin have been suggested to be the critical
mechanism for the anti-cancer activity of BV [12].
It is well documented that induction of apoptosis is
the most effective strategy by which anti-cancer agents
target cancer cells [13]. Chemotherapy agents can induce
apoptosis signaling through two major pathways. One is
the mitochondrial (intrinsic) pathway and the other
one is the death receptor (extrinsic) pathway. Cascadingtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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provokes activation of downstream caspase-3, which is
one of the key agents of apoptosis. Activated caspase-3
cleaves a wide array of substrates, such as poly(ADP-ri-
bose) polymerase (PARP), a DNA repair enzyme, and in-
evitably leads to cell death [14,15].
Cisplatin (cis-diammine dichloroplatinum II) is one of
the most remarkable drugs which is used separately or
in combination with other chemotherapy agents to treat
different types of tumors [16,17]. Despite the success of
cisplatin and platinum-based drugs, they have presented
serious clinical side effects [18,19]. Therefore, much
effort has been focused on identifying novel anti-tumor
agents and examining new approaches to increase their
damage to tumor cells at a lower concentration than
conventional chemotherapy drugs [20].
The significant similarities between the coordination
chemistry of palladium (II) and platinum (II) compounds
have generated lines of research on Pd (II) complexes as
anti-tumor components [21]. Recently we stated at the
FAOBMB conference that [Pd (bpy) (Pi-Pydtc)]NO3, as a
novel palladium complex designed and synthesized by
our research group, exerts clear anti-tumor effects on
human lymphoblastic leukemia MOLT-4 cells [22].
In the present study, we first examined the cytotoxic
effect of BV on the MOLT-4 cancerous cell line, then
the synergistic effects of BV and the novel Pd (II), [Pd
(bpy)(Pi-Pydtc)]NO3, on these cells. This investiga-
tion employed the following techniques: MTT assay,
morphological analysis, flow-cytometry assay and the
caspase3 activity assay.Methods
Bee venom collection and novel Pd (II) complex
preparation
Venom from the Iranian honey bee (Apis mellifera) was
prepared by placing bees on a 6-mm wire grid, which
was electrically pulsed. The bees then produced venom
that dropped onto a glass slide, from which it was col-
lected and freeze-dried according to the method of
Lariviere and Melzack [23], whereas the novel complex
of the Pd (II) was designed and synthesized by our re-
search group [24].Cell culture
The human T-cell acute lymphoblastic leukemia MOLT-
4 cells were purchased from the Pasteur Institute
(Tehran, Iran). Cells were maintained in RPMI-1640
medium (Gibco, UK) and supplemented with 10% fetal
bovine serum (Gibco, UK), penicillin at 100 units/mL,
and streptomycin at 100 μg/mL, in a humidified incuba-
tor filled with 5% CO2 at 37°C. The medium was re-
placed every 48 hours.MTT cytotoxicity assay
In order to determine the cytotoxic effects of BV separ-
ately and in combination with Pd (II) complex on the
MOLT-4 cells, cell viability was tested by MTT (3[4,
5-dimethylthiozol-2-yl]-2,5-diphenyl tetrazolium brom-
ide) assay. The cells were first seeded into 24-well cul-
ture plates (Nunc, Denmark) at a density of 1.0 × 105
cells/mL and subsequently incubated in a humidified 5%
CO2 environment for one hour. The cells were then
treated with BV at 1, 3, 6 and 8 μg/mL for 24 and
48 hours, the concentrations chosen as a result of pre-
cipitation of the BV in the medium. Non-treated cells
were used as controls.
MTT (100 μL of 5 mg/mL) (Sigma, USA) was added
to each well and incubated at 37°C for four hours. The
dark blue crystals were dissolved by adding 1000 μL of
0.04 M HCl/isopropanol. After an overnight incubation
in darkness, optical density (O.D.) was read at a wave-
length of 570 nm using a spectrophotometer. The O.D.
values of the experimental groups were divided by those
of the untreated control group, and the results were
presented as the percentage of cell viability.
By calculating the minimum BV dosage that killed
MOLT-4 cells, we exposed cells to the lowest lethal dos-
ages of BV and Pd (II) complex simultaneously [1 μg/mL
BV/0.85 μM Pd (II) complex, 3 μg/mL BV/0.85 μM Pd
(II) complex and 6.3 μg/mL BV/0.85 μM Pd (II) com-
plex] for 24 hours. Cell survival was determined as de-
scribed above.Morphological analysis
To monitor the effect of BV alone and in combination
with Pd (II) complex on MOLT-4 cells, the cells were
treated with BV and BV/Pd (II) complex, then morpho-
logically analyzed under an inverted microscope to see
whether these components were able to induce conden-
sation of their nuclei.Apoptosis analysis by flow cytometry
In this study, apoptosis was measured by means of a
flow cytometry assay. Cells were treated with BV and
BV/Pd (II) complex for 24 hours. Then, these cells were
harvested and washed with PBS. After washing, the cells
were resuspended in 100 μL Annexin-V (Abcam, UK)
(diluted 1:100 in blocking buffer BSA/PBS 1%) and sam-
ples were incubated overnight at 4°C. Next, the cells
were washed with PBS and centrifuged (2000 rpm/10 mi-
nutes); the supernatant was aspirated and cells were
incubated in the dark with 50 μL fluorescein-labeled
goat anti-rabbit secondary antibody (diluted 1:100 in
blocking buffer BSA/PBS 1%) for 45 minutes at 37°C.
Finally, 300 μL of 1% formaldehyde was added to each
tube and data were analyzed by flow cytometry using a
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Dickinson, USA).
Caspase activity assay
Caspase activity was determined by colorimetric assay
using a caspase-3 activation kit (Abcam, UK) according
to the manufacturer’s protocol. Briefly, cells were first
treated with different concentrations of BV (3.15, 6.3
and 12.6 μg/mL) and BV/Pd (II) complex [0.5 μg/mL
BV/0.425 μM Pd (II) complex and 1 μg/mL BV/0.85 μM
Pd (II) complex], and then lysed in lysis buffer. The
supernatant was collected and incubated with the
supplied reaction buffer, containing dithiothreitol and
substrates, at 37°C for two hours. The reaction was mea-
sured by changes in the absorbance at 405 nm using a
microplate reader. The level of caspase enzymatic activ-
ity in the cell lysate was proportional to the optical
absorbance, which was read with an ELISA reader
(Biotech, USA).
Statistical analyses
Statistical differences were determined by one-way ana-
lysis of variance (ANOVA), with the results expressed as
mean ± standard error of the mean (S.E.M.) for three in-
dependent experiments (n = 3). Differences were consid-
ered significant for p > 0.01.
Results
Cell viability assay
In order to determine the optimal dose and time of cyto-
toxic effect of BV alone and in combination with this
novel Pd (II) complex on MOLT-4 cells, an MTT assay
was performed. The cells were treated with BV at vari-
ous concentrations for 24 and 48 hours and with BV/Pd
(II) complex for 24 hours. The respective viabilities of
cells treated with BV at concentrations of 1, 3, 6 and
8 μg/mL for 24 hours were 87.5 ± 0.500, 81.5 ± 2.500,Figure 1 Growth inhibition and cell death were determined via MTT a
of BV/Pd (II) complex on viability of MOLT-4 cells. Results are presented as
different from the control.54 ± 2.828 and 44.5 ± 3.5 in relation to the control value.
The viabilities of cells treated with BV at the concentra-
tions of 1, 3 and 6 μg/mL for 48 hours were 38 ± 4, 28 ±
2.309 and 25.6 ± 2.728 relative to the control value, re-
spectively (Figure 1A).
The viabilities of cells treated with BV/Pd (II) complex
at concentration of 1 μg/mL BV/0.85 μM Pd (II)
complex, 3 μg/mL BV/0.85 μM Pd (II) complex and
6.3 μg/mL BV/0.85 μM Pd (II) complex for 24 hours
were 49.33 ± 1.435, 35 ± 0.5774, 27.33 ± 1.453 in relation
to the control value, in that order (Figure 1B).
These results reveal that the cytotoxic effect of BV
alone and in combination with Pd (II) complex on
MOLT-4 cells is dose- and time dependent (Figure 1A
and B). Based on these data, the respective 50% cyto-
toxic concentrations (Cc50) of the BV after 24 and
48 hours of incubation were 6.3 and 0.6 μg/mL. The
Cc50 value of BV in combination with Pd (II) complex
was 1 μg/mL BV/0.85 μM Pd (II) complex after 24 hours
of incubation. The optimal dose and treatment time of
BV alone and in combination with Pd (II) complex to be
used in subsequent experiments were set according to
Cc50 values of these components at 24 hours.Cellular morphological changes with BV and BV/Pd (II)
complex
To examine the effects of BV and BV/Pd(II) complex
on MOLT-4 cell morphology, cells were treated with
BV and BV/Pd (II) complex and examined by phase-
contrast microscopy. As shown in Figure 2, cells
treated with BV (Figure 2B) or with BV/Pd complex
(Figure 2C) displayed greater nuclear condensation
than the control group (Figure 2A). This morpho-
logical characteristic suggests that BV alone or in
combination with Pd (II) complex induces apoptotic
cell death in MOLT-4 cells.ssay. (A) Dose- and time-dependent effect of BV and (B) dose effect
mean ± S.E.M. n = 3; ** p > 0.01 and *** p > 0.001 significantly
Figure 2 Effect of BV and BV/Pd (II) complex on the morphology of MOLT-4 cells. Photomicrographs from inverted microscope. Condensed
nuclei obviously indicate apoptosis. (A) Controls, (B) cell treated with BV, (C) cells treated with BV/Pd (II) complex.
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To prove that BV and BV/Pd(II) complex induce
apoptosis in MOLT-4 cells, a flow cytometric ana-
lysis with Annexin-V was performed (Figure 3). The
results confirmed that the cells exposed to BVFigure 3 Characterization of BV and BV/Pd (II) complex-induced apop
without any component (control), (B) with BV and (C) with BV/Pd (II) comp
of these two components simultaneously [1 μg/mL BV/0.85 μM Pd (II) comalone or in combination with Pd (II) complex for
24 hours enter the early stage of apoptosis. Apop-
tosis was induced in 32.30% of the cells exposed
simultaneously to the Cc50 value of these two
components.tosis in MOLT-4 cells by flow cytometry. Cells were cultured (A)
lex for 24 hours. Note that 32.30% of the cells exposed to Cc50 value
plex] enter early apoptosis stage.
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Caspase-3 enzyme activity was measured by a colorimet-
ric assay. The enzyme activity assay revealed that
caspase 3 was not affected by BV. The optical density of
the samples exposed simultaneously to BV and Pd (II)
complex increased from 0.075 to 0.1033 and from 0.075
to 0.14266 at 1/2 Cc50 [0.5 μg/mL BV/0.425 μM Pd (II)
complex] and Cc50 [1 μg/mL BV/0.85 μM Pd(II) com-
plex], respectively (Figure 4).
Discussion and conclusions
Although it has been previously reported that bee
venom can inhibit human cancer cell growth through in-
duction of apoptosis in many cancer cell lines such as
prostate cancer, breast cancer and melanoma, there is
no finding of the induction of apoptosis in human T cell
acute lymphoblastic leukemia cells by BV [6-8]. Based
on our knowledge, the present study is the first report
about examination of the synergistic effect of BV with a
palladium metal-based component.
Analysis of cytotoxicity by MTT assay proved that BV
is both time- and dose-dependent in its cytotoxic effects,
given that the Cc50 values of this component were 6.3
and 0.6 μg/mL after 24 and 48 hours, respectively. Due
to the inconsistency in the MTT assay data – as a result of
precipitation of the BV at high concentrations after 24 and
48 hours, and at low concentrations after 48 hours – only
the concentrations less than 10 μg/mL were applied in
these experiments. At these concentrations the findings
were acceptable, except at 8 μg/mL after 48 hours, which
again resulted in precipitation of the BV.
The lethal dosage of BV in MOLT-4 cells is about
6.3 μg/mL, which is lower than that for lung cancer cells
reported by Jang et al. [9] (10 μg/mL), but exceeds that
of leukemia U937 cells (about 2 μg/mL after 48 hours),Figure 4 Results of caspase-3 enzyme activity assay. Cells treated (A) w
measured at 405 nm. The OD values were not altered by increasing BV, wh
(II) complex [0.5 μg/mL BV/0.425 μM Pd (II) complex] to Cc50 BV/Pd (II) com
Data represent mean ± SEM of three different experiments. n = 3; *** p >as well as human melanoma A2058 cells (2 μg/mL after
one hour) [8,10]. However, BV required different dura-
tions to induce cell death in these distinct types of
cancerous cells. Such differences may be due to the bio-
logical and genetic variations between the investigated
cell types. Morphological analysis and the results of flow
cytometry indicated that the type of cell death induced
by BV is apoptosis.
The present data have also revealed that expression of
caspase-3 protein in MOLT-4 cells exposed to BV is
down-regulated. Ip et al. [11], when examining the effect
of honey bee venom on human cervical epidermoid car-
cinoma Ca Ski cells, observed that bee venom induced
cell cycle arrest and apoptosis in these cells in caspase-
dependent and caspase-independent pathways [11]. Tu
et al. [8] also indicated that bee venom induces calcium-
dependent but caspase-independent apoptotic cell death
in human melanoma A2058 cells.
On the contrary, BV induced apoptosis in human
leukemia U937 cells through down-regulation of the
ERK and Akt signaling pathway, with Bcl-2 and caspase-
3 as the key regulators [10]. A large amount of evidence
indicates that apoptosis-induced factors (AIF) and endo-
nuclease G (EndoG) act as major apoptosis agents in the
caspase-independent cell death pathway [25-28].
In addition to the abovementioned effects, we proved
that lethal effects of Pd complex were potentiated by
adding a non-lethal dose of the bee venom. On the other
hand, BV exerts a strong synergistic effect on the Pd (II)
complex. Our preliminary data, which were presented at
the FAOBMB Conference, indicated that 1.7 μM [Pd
(bpy)(Pi-Pydtc)]NO3 produces a cytotoxic effect on the
MOLT-4 cells. It was also demonstrated that the lethal
dose of this newly synthesized palladium complex can
induce apoptosis in these cells [22].ith BV and (B) with BV/Pd (II) complex. The optical density was
ile the OD values rose following a dose increase from 1/2Cc50 BV/Pd
plex [1 μg/mL BV/0.85 μM Pd (II) complex] compared to the control.
0.001 significantly different from the control.
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and palladium (II) complex were consumed simultan-
eously, the combination of 1 μg/mL BV with 0.85 μM
Pd (II) complex induces MOLT-4-cell apoptosis in a
caspase-3-dependent manner. Orsolic [29], while investi-
gating cytotoxic effects of bee venom applied alone or in
combination with the DNA-damaging drug bleomycin
on HeLa and V79 cells, found that bleomycin caused a
dose-dependent decrease in cell survival. When used
with a non-lethal dose of the BV, its lethal effect was po-
tentiated. The author inferred that BV, by preventing re-
pair of damaged DNA, increases bleomycin lethality and
inhibited recovery from bleomycin-induced damage [29].
Because DNA is the main target of palladium metal-
based complexes, we may conclude that BV is able to
potentiate the lethality effect of [Pd (bpy)(Pi-Pydtc)]NO3
in this manner. In summary, the results of the present
study suggest that the BV induces apoptosis in human
lymphoblastic leukemia cells and, if further studies on
animal models confirm these results, that bee venom
may be used with customary chemotherapy agents to
improve their cytotoxic effects.
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